1. Resection arthrodesis and osteoarticular allografts reconstruction after resection of primary bone tumors around the knee: Long‐term clinical outcomes and prognostic factors for failure of biological reconstruction
- Author
-
Winai Sirichativapee, Weerachai Kosuwon, Taweechok Wisanuyotin, and Permsak Paholpak
- Subjects
musculoskeletal diseases ,medicine.medical_specialty ,Prognostic factor ,medicine.medical_treatment ,Arthrodesis ,Bone Neoplasms ,Resection ,03 medical and health sciences ,0302 clinical medicine ,medicine ,Humans ,030212 general & internal medicine ,Significant risk ,Retrospective Studies ,Chemotherapy ,Bone Transplantation ,business.industry ,General Medicine ,Allografts ,Prognosis ,Surgery ,Treatment Outcome ,Primary bone ,Oncology ,030220 oncology & carcinogenesis ,business - Abstract
Aim The biological reconstruction of the knee with osteoarticular allografts and resection arthrodesis have been reported but there has not yet been a direct comparison between both these procedures. This study aimed to identify the prognostic factors that influence failure of biological reconstruction and compared the results between both procedures. Methods Between 1994 and 2017, we performed 92 limb-sparing procedures using resection arthrodesis (n = 53) and osteoarticular allograft reconstruction (n = 39) for the management of primary bone tumors around the knee. The minimum follow-up time was 2 years in both groups. Results The failure rate of reconstruction in the osteoarticular allograft and resection arthrodesis group was 48.7% and 39.6%, respectively (p = 0.75). The mean MSTS score in the osteoarticular allograft and resection arthrodesis group was 23.7 and 21.8, respectively (p = 0.01). The significant risk factor for failure after biological reconstruction was the administration of chemotherapy (p = 0.001; HR = 3.39; 95% CI, 1.60-7.17). Conclusion Patients who underwent osteoarticular allograft had a better functional outcome than those who underwent resection arthrodesis reconstruction, but clinical outcomes between the groups were comparable. Chemotherapy is a significant adverse prognostic factor for failure of biological reconstruction.
- Published
- 2021
- Full Text
- View/download PDF